-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
January 01, 2009 - Topic Description
Nominator: Individual
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
January 01, 2007 - Topic Description
Nominator: Public payer
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - Comment Response
Peer Reviewer
#1
Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description
of the findings to the beginning of the result … We have included a
description of and a citation for the DECIDE study in the
“Future Areas for Research … Peer Reviewer
#2
Background The Background was thorough in its description of the clinical
problem … Peer Reviewer
#4
Methods “Systematic review” may not be the most appropriate description of
this
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
September 21, 2012 - in
subgroups; availability of strong a priori biological
and epidemiological evidence; detailed description … endpoints related to
outcomes, prespecification of hypotheses relating
to subgroup effects, and detailed description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - However, a
description of meta-analysis goes beyond
this report. … The description of industry funding has been
removed. … The description of industry funding has been
removed. … However, there was an error in the
description of second study that has been
corrected. … However, the description of
methotrexate has been expanded.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms
associated with anticoagulant use in the … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … 8, we will create a table to record the source of each relevant toolkit
along with a 1–2 sentence description … Question 8, we will create a table to record the source of each relevant toolkit along with a 1–2 sentence description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - practice or comparing report
card types (or assessing data
quality of a report card)
• No clear description … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … Review Question 8, we will list the name
and source of each relevant toolkit along with a 1-2 sentence description … MHS = Making Healthcare Safer
Literature Searches for Studies of Effectiveness
Description of Included
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
October 15, 2024 - progesterone or norethindrone
acetate)).mp.
26677
26
Structure # Searches Results Description … or insert*)).ti,bt,ab,kf.
9482
27
Structure # Searches Results Description
26 Paroxetine … ti,bt,kf.
37578
29
Structure # Searches Results Description
56 ("use" adj3 (medication … or therap*)).ti,bt,ab,kf.
155871
30
Structure # Searches Results Description
59 ( … ti,bt,ab,kf.
652
31
Structure # Searches Results Description
63 (access* adj3 (service
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
November 20, 2024 - There doesn’t appear to be any description of the
decades of LCA work on waste management. … This section is much too short and just
appears to be a description of several studies with
no description … This is not a comprehensive description of the
results and does not give basic information about
system … The sections were intentionally reordered
and a description has been added to the
section to introduce … Peer reviewer #1 Findings Page 13 line 47, the description of LCA and the
terminology used here is wrong
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
June 21, 2013 - Topic Description
Nominator(s): Health care professional association
Nomination The nominator is
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
June 24, 2014 - Topic Description
Key Questions: 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
January 01, 2009 - Topic Description
Nominator: Organization
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
January 01, 2009 - Topic Description
Nominator: Organization
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0456_07-27-2011.pdf
January 01, 2011 - Topic Description
Nominator: Health care professional association
Nomination
Summary:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
January 01, 2009 - Topic Description
Nominator: Individual
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
January 01, 2008 - Topic Description
Nominators: 1 anonymous individual, 1 individual
Nomination
Summary:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
January 01, 2008 - Topic Description
Nominator: Public payer
Nomination
Summary:
The nominator is interested
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
November 04, 2020 - We have expanded the description of the
inclusion and exclusion criteria and
explained how they have … Suggest
keeping all approach/method description
together. … However, the
description of study participants in the figure
suggests that other comorbidities are … However, "community" might warrant
additional description. … The description of the table is also a
little confusing - percentages of unreported data?
Noted.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/obsessive-compulsive-disorder-disposition-comments.pdf
December 06, 2024 - However, most
studies did not provide a
detailed description of
providers, precluding a more
granular … description.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
May 26, 2017 - There is a short but
concise description of ASD and the problems associated with the
condition. … We did not set specific parameters for small,
medium, or large; we acknowledge that our
description … Description of included studies well done; table 2 provides a good
overview of types of studies included … TEP Reviewer
#5
Results I am not sure from the description why N-acetylcysteine is not low
SOE. … TEP Reviewer
#5
Results I am not sure from the description why melatonin is not low SOE.